Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Browse archives for older articles from 2018 , 2017 , 2016 (all articles may be found in search)
These articles are Open Access.

Did you know how medwireNews writes our articles?


Date Title Topic
12 Feb 2019 Radium-Anti-Androgen Combination Not Recommended For mCRPC Prostate Cancer - Anticancer Agents - Radiation Oncology
11 Feb 2019 Meta-Analysis Shows Benefit Of Dose-Intense Chemotherapy For Early-Stage Breast Cancer Breast Cancer - Anticancer Agents
08 Feb 2019 Ultrasound-Guided Conservative Management May Be Feasible For Benign Ovarian Masses Ovarian Cancer - Imaging
07 Feb 2019 Celecoxib Use During Neoadjuvant Chemotherapy Linked To Poorer Breast Cancer Survival Breast Cancer - Anticancer Agents
06 Feb 2019 RAINFALL Washes Away First-Line Ramucirumab Plus Chemotherapy For Metastatic Gastric Cancer Gastric Cancer - Anticancer Agents
05 Feb 2019 Five-Year Findings Confirm Pembrolizumab Efficacy For Advanced Melanoma Melanoma - Immunotherapy
04 Feb 2019 Hypofractionated Radiotherapy Regimen Feasible After Mastectomy Breast Cancer - Radiation Oncology
01 Feb 2019 Docetaxel Use With ADT Challenged For High-Risk, Nonmetastatic Prostate Cancer Prostate Cancer - Anticancer Agents
31 Jan 2019 Disease-Free Survival ‘Appropriate’ Surrogate Endpoint For HER2-Positive Early Breast Cancer Breast Cancer - Anticancer Agents
30 Jan 2019 PD-1 Inhibitor Efficacy Predicted By Immune-Related Adverse Events Immunotherapy - Complications/Toxicities of Treatment
29 Jan 2019 Breast Cancer Radiotherapy-Associated Angiosarcoma Incidence, Survival Described Breast Cancer - Soft Tissue Sarcomas
28 Jan 2019 Avelumab Shows ‘Encouraging’ Activity For Heavily Pretreated Ovarian Cancer Ovarian Cancer - Clinical Research - Immunotherapy
25 Jan 2019 TILs Predict Early-Stage Triple-Negative Breast Cancer Survival Breast Cancer - Pathology/Molecular Biology
24 Jan 2019 Patient-Reported Symptom Monitoring Improves Lung Cancer Survival Thoracic Malignancies
23 Jan 2019 REACH-2 Indicates Ramucirumab Efficacy For HCC Patients With High α-Fetoprotein Hepatobiliary Cancers - Anticancer Agents